
-
Gilgeous-Alexander leads Thunder rally past Timberwolves
-
Century-old Tokyo geisha festival revives dying art
-
High-flying young electricians wire UK energy switch
-
Germany's infrastructure push needs more than money
-
China slams US 'bullying' over new chip warnings
-
Canada seeks to send 'strong message' with Ukraine at G7 finance talks
-
'Fusterlandia': Cuban fishing town turned mosaic wonderland
-
Severe drought strains wildlife and tourism in Florida's Everglades
-
Villagers vow to fight new Panama Canal reservoir 'to the end'
-
'Being a woman is a violent experience,' says Kristen Stewart
-
Canadian host of G7 finance talks 'optimistic' despite trade turmoil
-
G7 finance chiefs gather with Trump tariffs, Ukraine war in focus
-
Oasis fans could spend £1 bn on UK concerts: study
-
Epic Games says Fortnite back on Apple's US App Store
-
Europe increases pressure on Israel over Gaza offensive
-
Costa Rica prison guards catch drug-smuggling purr-petrator
-
'We had a lot of fun' - De Bruyne proud of Man City legacy
-
US expects Russia offer soon as Zelensky sounds warning
-
De Bruyne departs, Rodri returns as Man City close in on Champions League
-
Trump pushes Republicans to back 'big, beautiful' tax bill
-
Trump unveils plans for 'Golden Dome' missile shield for US
-
NFL players cleared to take part in 2028 Olympics: league
-
Peppa Pig gets new baby sister
-
G7 finance leaders gather in Canada as trade worries cloud outlook
-
Last call for 'Norm!' as Cheers star George Wendt dies
-
Mother of Combs's ex Cassie testifies at music mogul's trial
-
US limits Covid boosters to over-65s or those at high risk
-
Google ramps up search with AI mode
-
Kevin Spacey says 'glad to be working again'
-
Wing wizard Maguire makes case for Man Utd defence in Europa League final
-
Man Utd's Amorim 'can't explain' why fans back him despite dismal season
-
Back at Cannes, Iran filmmaker Panahi defies repression
-
Tony Parker's French club 'not viable', auditing body says
-
Google ramps up AI features in search engine
-
Trump admin ends halt on New York offshore wind project
-
Suryavanshi helps lowly Rajasthan end IPL campaign with win
-
Dissident director Panahi takes on Iran's jailors in Cannes comeback
-
Women's Champions League trophy recovered by police after theft
-
Family mourns Mexican naval cadet killed in New York bridge crash
-
Chanel reports 28% drop in full-year profit
-
Man City unveil De Bruyne tribute as star prepares to say farewell
-
Ukrainians feel no closer to peace after Trump-Putin call
-
European nations increase pressure on Israel to stop broad Gaza offensive
-
McCullum urges England to show 'humility' after rocky spell
-
Top-selling French rapper laid to rest after death aged 31
-
European stocks close higher as Wall Street dips
-
EU plans two-euro flat fee on small parcels from outside bloc
-
Chess great Carlsen held to draw by 143,000 players
-
US to limit Covid boosters to over-65s or those at high risk
-
Del Toro holds Giro lead as Hoole wins rainy time trial

Kenya's desperate need for more snake antivenom
Writhing in pain on a hospital bed in a Kenyan coastal town, teenage snakebite victim Shukurani Konde Tuva faced the grim reality of his left leg from above the knee being amputated.
The 14-year-old was bitten by a puff adder -- a venomous snake and the most common snakebite in sub-Saharan Africa -- while eating outdoors in his village near the town of Malindi more than a month ago.
His family rushed him to hospital two hours away by motorbike, but the antivenom he received did not help.
"My son's leg is totally rotten and maggots are even emanating from it. They'll have to cut it," said his distraught mother, Mariamu Kenga Kalume.
Some 5.4 million people are bitten by snakes each year globally and roughly half are poisoned by venom, according to World Health Organization (WHO) data.
Up to 138,000 people die and 400,000 suffer permanent physical effects, though the WHO says the numbers are a "gross underestimation" since an estimated 70 percent of cases go unreported.
Traditional beliefs and myths skew the data as some victims turn to home-grown remedies or attribute bites to voodoo "sent by their enemies" instead of seeking medical care.
- 'Snake stone' -
A few kilometres (miles) from where Shukurani lay in pain, traditional healer Douglas Rama Bajila showed AFP the concoctions he uses to "suck out" venom.
One popular remedy is the "snake stone", made from a cow's bone and sold for about $1.
Bajila said it can be reused multiple times: it simply needs to be soaked in milk for a few hours to "recharge".
One was placed on Shukurani's leg as he was transported to hospital but unfortunately fell off along the way, his mother said.
Experts worry that by using traditional snakebite remedies, patients are losing precious time but they are popular because antivenom treatments are expensive.
Antivenoms cost up to 8,000 shillings (about $62) per vial, and some patients require as many as 20 doses.
Ruth Kintalel, 30, from a pastoralist community in Kajiado county near the capital Nairobi, said she spent over five months in hospital after a red spitting cobra bit her in her sleep.
"My husband sold our livestock to cover the rising hospital bill," said Kintalel, who is still paralysed in her right arm seven years later.
- 'Bad reactions' -
Experts say Kenya receives between 10,000 and 30,000 vials of antivenom per year and needs 100,000.
Antivenom is made by "milking" venom from the fangs of snakes, which is then diluted and injected in small doses into animals such as horses, which produce antibodies that can be extracted for use in humans.
Using snakes from different regions, even of the same species, can reduce the effectiveness of the antivenom and cause "really bad reactions", said Kyle Buster Ray, a curator at the Watamu Snake Farm on the Kenyan coast.
Kenya's stock of antivenom is not always effective because much comes from other countries like India, he said.
His farm houses over 400 venomous and non-venomous snakes and seeks to re-establish faith in antivenom that has been undermined by too many shoddy treatments.
It offers free antivenom to critical cases locally, but stocks are limited.
The farm also trains communities in life-saving snakebite responses.
During a session attended by AFP, about half the community said they had been bitten at least once, and nearly all had initially turned to traditional medicines.
Many showed signs of paralysis, with one suffering partial blindness.
- 'Trauma' -
In Nairobi, the Snakebite Research and Intervention Centre within the Kenya Institute of Primate Research is working on an antivenom specific to the country and applicable to multiple species.
Valentine Musabyimana, a research fellow at the institute, said they "are aiming for an antivenom where a patient will require only one vial with great potency".
Government subsidies should make it affordable, she hopes, though it is expected to take about two years before the antivenom is available.
That is too late for 14-year-old Shukurani.
At the snake farm, Ray warned that the boy faced psychological as well as physical consequences.
"Someone has watched their limb completely rot... there's a lot of mental trauma," Ray said.
J.Horn--BTB